As shown in Fig. 3, the expression levels of SPC25 in cholangiocarcinoma, colon adenocarcinoma, pancreatic adenocarcinoma, rectum adenocarcinoma, LIHC, and stomach adenocarcinoma were significantly higher than those in non-neoplastic tissues. This evidence concerns the gene SPC25 and pancreatic adenocarcinoma.